Powered by Biocytogen's proprietary RenMice® platforms and an AI-driven antibody discovery workflow, we offer an extensive off-the-shelf library of more than 1 million validated, fully human therapeutic antibodies against over 1,000 targets, enabling rapid and efficient drug discovery.
Catalog Highlights
Interested in a specific target or asset?
Contact us to learn more, request a detailed data package, or schedule a meeting.
